Accretion Pharmaceuticals
add_icon

Accretion Pharmaceuticals

155.70
+3.80
(2.50%)
Market Cap
173.08 Cr
PE Ratio
17.46
Volume
6,000.00
Day High - Low
158.15 - 152.50
52W High-Low
153.75 - 53.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
173.08 Cr
EPS
9.03
PE Ratio
17.46
PB Ratio
3.09
Book Value
49.21
EBITDA
14.95
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
44.44
Debt to Equity
1.33
Forecast For
Actual

Company News

View All News
Caret
neutral
Accretion Pharmaceuticals will hold investor meets in Mumbai on June 26, 2026. The meetings include one-on-one and group sessions.
neutral
Promoters of Accretion Pharmaceuticals confirmed no shares were encumbered in FY26. The disclosure was made to NSE under SEBI takeover regulations.
positive
Accretion Pharmaceuticals filed its FY26 media release under Regulation 30, reporting net revenue of ₹89.63 crore, up 56.21% YoY, and PAT of ₹9.67 crore, up 42.30% YoY.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,879.00
#1 4,50,835.04
39.08
#1 58,220.10
6.38
#1 11,565
25.80
66.93
6,719.50
1,78,381.61
69.79
10,560.00
8.73
2,520
13.44
55.02
4,494.00
1,52,097.38
71.28
13,886.20
20.34
2,138
-26.91
55.98
1,443.30
1,16,586.99
30.07
29,044.60
2.24
3,870
-55.32
65.05
1,361.10
1,13,603.26
26.67
33,593.30
-0.44
3,998
-86.05
64.53
1,111.70
1,11,863.03
21.58
26,719.70
13.65
5,242
7.82
61.12
2,375.10
1,08,552.33
#1 20.22
27,487.50
19.98
5,345
#1 87.72
63.99
2,501.10
1,03,246.68
52.76
14,277.60
12.03
1,750
31.75
59.95
1,552.00
90,140.41
25.36
33,384.70
3.21
3,376
1.99
63.83
1,454.20
78,505.94
88.23
6,867.80
#1 22.01
890
21.18
65.69
Growth Rate
Revenue Growth
55.88 %
Net Income Growth
43.24 %
Cash Flow Change
149.96 %
ROE
63.50 %
ROCE
248.60 %
EBITDA Margin (Avg.)
-20.15 %

Yearly Financial Results

Annual Financials
2024
2025
2026
TTM
Revenue
13
58
90
0
Expenses
11
46
75
0
EBITDA
3
12
15
0
Operating Profit %
19 %
21 %
17 %
0 %
Depreciation
0
1
1
0
Interest
0
1
1
0
Profit Before Tax
2
10
13
0
Tax
1
3
3
0
Net Profit
2
7
10
0
EPS in ₹
1.96
8.48
9.03
0.00

Balance Sheet

Balance Sheet
2024
2025
2026
Total Assets
27
40
77
Fixed Assets
5
6
13
Current Assets
22
34
61
Capital Work in Progress
0
0
0
Investments
0
0
28
Other Assets
22
34
0
Total Equity & Liabilities
27
40
77
Current Liabilities
15
23
21
Non Current Liabilities
7
1
1
Total Equity
6
15
55
Reserve & Surplus
2
7
44
Share Capital
4
8
11

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
0
0
Investing Activities
-6
-2
Operating Activities
-12
6
Financing Activities
17
-4

Share Holding

% Holding
Sept 2024
Jan 2025
May 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
100.00 %
100.00 %
73.50 %
73.50 %
73.52 %
73.52 %
73.52 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
19.44 %
21.46 %
22.85 %
22.01 %
22.92 %
Others
0.00 %
0.00 %
7.06 %
5.04 %
3.63 %
4.47 %
3.56 %
No of Share Holders
8
8
8
1,628
1,498
1,179
1,182

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Jun 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Jun 2025 66.05 69.80
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 56.75 66.15
08 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 May 2026 108.65 112.50

Technical Indicators

RSI(14)
Neutral
66.70
ATR(14)
Volatile
6.88
STOCH(9,6)
Neutral
70.40
STOCH RSI(14)
Oversold
18.75
MACD(12,26)
Bearish
-0.38
ADX(14)
Strong Trend
33.74
UO(9)
Bearish
68.11
ROC(12)
Uptrend And Accelerating
10.07
WillR(14)
Overbought
-8.19